FDA greenlights AquaBounty salmon facility in Indiana

The US Food and Drug Administration (FDA) approved an application by AquaBounty Technologies on Friday to raise its AquAdvantage Salmon at a land-based contained facility near Albany, Indiana.

However, while the Indiana facility is approved for production, the company is prohibited from importing the eggs necessary for producing genetically engineered (GE) salmon at the facility because of a requirement in FDA’s current appropriations law.

Under the Federal Food, Drug, and Cosmetic Act (FD&C Act), the FDA is required to review New Animal Drug Applications (NADAs) for safety and effectiveness.